Immediate Impact
25 standout
Citing Papers
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
2024 Standout
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
Works of Yuma Wada being referenced
Epigallocatechin‑3‑gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer‑associated fibroblasts
2022
A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yuma Wada | 173 | 167 | 118 | 119 | 70 | 452 | |
| Jungang Liu | 108 | 212 | 151 | 130 | 48 | 446 | |
| Wenqing Hu | 79 | 129 | 85 | 143 | 61 | 424 | |
| Cristina Díaz del Arco | 167 | 147 | 152 | 63 | 67 | 394 | |
| Toshihiro Nakao | 158 | 215 | 187 | 107 | 58 | 451 | |
| Takahito Sugase | 153 | 141 | 128 | 155 | 56 | 460 | |
| Hong Guo | 161 | 95 | 81 | 156 | 37 | 511 | |
| Xiongying Jiang | 109 | 117 | 121 | 71 | 37 | 467 | |
| Guanyu Yu | 145 | 127 | 101 | 80 | 41 | 416 | |
| Keigo Murakami | 129 | 222 | 117 | 123 | 45 | 506 | |
| Federico Selvaggi | 93 | 187 | 96 | 166 | 42 | 442 |
All Works
Login with ORCID to disown or claim papers
Loading papers...